Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Conference Reports for NATAP The International Liver Congress EASL - European Association for the Study of the Liver June 21-24 2023 Back Pemvidutide Cuts NAFLD Liver Fat and Weight Through 24 Weeks EASL Congress 2023, June 21-24, Vienna Mark Mascolini Pemvidutide, a novel multiactive agent being developed for obesity and nonalcoholic steatohepatitis (NASH), promoted quick and large drops in liver fat content (LFC), weight, and liver enzymes after 12 and 24 weeks in a 94-person placebo-controlled trial [1]
Vivek Lal, MD (30:32.501) So I am not going to use this platform to make any disease claims because we can't
Read more about this: For more information about the effects of antioxidants on blood flow, performance, and training adaptations, be sure to check out our recent article: Antioxidants for Lifters: A Review of the Evidence.
Pierre-Louis: It really feels like, especially if youre using these drugs for weight loss, you really should be weighing the pros and cons and really be thinking through the long term, especially within the back of your head, that you might not actually be on these drugs forever
